Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC

Lasers in Surgery and Medicine

Volumn 32, Issue 1, 2003, Pages 61-68

  Krueger, Thorsten ^a   Altermatt, Hans J ^b   Mettler, Daniel ^c   Scholl, Beatrix ^a   Magnusson, Lennart ^a   Ris, Hans Beat ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b S   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Dosimetry; MTHPC foscan; Neoplasm; Nude mice; Pegylation; Photodynamic therapy; Pleura; Pleural mesothelioma; Pneumonectomy; Swine; Thorax; Xenograft

Indexed keywords

PEGYLATED 3 TETRAHYDROXYPHENYLCHLORIN; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIODE LASER; DOSIMETRY; FEMALE; HUMAN; HUMAN CELL; LUNG RESECTION; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; PLEURA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SWINE; THORAX; TISSUE INJURY; TUMOR NECROSIS; TUMOR XENOGRAFT;

ANIMALS; COMPUTER SYSTEMS; DISEASE MODELS, ANIMAL; FEMALE; MESOPORPHYRINS; MESOTHELIOMA; MICE; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLEURAL NEOPLASMS; PNEUMONECTOMY; POLYETHYLENE GLYCOLS; RADIOMETRY;

EID: 12244267743     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/lsm.10113     Document Type: Article

References (47)

1. Allen KB, Faber LP, Warren WH. Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am 1994;4:113-126.
2. Falkson G, Alberts AS, Falkson HC. Malignant pleural mesothelioma treatment: The current state of the art, Cancer Treat Rev 1988;15:231-242.
3. Gordon W, Antman KH, Greenberger JS, Weichselbaum RR, Chaffey JT. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 1982;8: 19-25.
4. Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma. A review. J Clin Oncol 1996;14:1007-1017.
5. Sugarbaker DJ, Norberto JJ. Multimodality management of malignant pleural mesothelioma. Chest 1998;113:61S-65S.
6. Baldini EH, Recht A, Strauss GM, DeCamp MM, Swanson SJ, Liptay MJ, Mentzer SJ, Sugarbaker DJ. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1997;63:334-338.
7. Baas P, Murrer L, Zoetmulder FA, Stewart FA, Ris HB, van Zandwijk N, Peterse JL, Rutgers EJ. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer 1997;76:819-826.
8. Pass HI, Tochner Z, DeLaney T, Smith P, Friauf W, Glatstein E, Travis W. Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg 1990;50:687-688.
9. Ris HB, Altermatt HJ, Inderbitzi R, Hess R, Nachbur B, Stewart JC, Wang Q, Lim CK, Bonnett R, Berenbaum MC. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: Initial clinical results. Br J Cancer 1991;64: 1116-1120.
10. Ris HB, Altermatt HJ, Nachbur B, Stewart CM, Wang Q, Lim CK, Bonnett R, Althaus U. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg Med 1996;18:39-45.
11. Takita H, Mang TS, Loewen GM, Antkowiak JG, Raghavan D, Grajek JR, Dougherty TJ. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: A phase II study. Ann Thorac Surg 1994;58:995-998.
12. Pass HI, Temeck BK, Kranda K, Thomas G, Russo A, Smith P, Friauf W, Steinberg SM. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997;4:628-633.
13. Moskal TL, Dougherty TJ, Urschel JD, Antkowiak JG, Regal AM, Driscoll DL, Takita H. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg 1998;66:1128-1133.
14. Stewart J. Meta-tetra(hydroxyphenyl)chlorin (mTHPC): A second generation photosensitizer for photodynamic therapy: A review. In: Horrobin D, editor. New approaches to cancer treatment. Unsaturated lipids and photodynamic therapy. London: Chuchill Livingstone. 1994.
15. van Geel IP, Oppelaar H, Oussoren YG, van der Valk MA, Stewart FA. Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin. Int J Cancer 1995;60:388-394.
16. Ris HB, Altermatt HJ, Stewart CM, Schaffner T, Wang Q, Lim CK, Bonnett R, Althaus U. Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: Optimization of the therapeutic index. Int J Cancer 1993;55:245-249.
17. Ris HB, Altermatt HJ, Nachbur B, Stewart JC, Wang Q, Lim CK, Bonnett R, Althaus U. Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma. Int J Cancer 1993;53:141-146.
18. Bonnett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J 1989;261: 277-280.
19. Ma L, Moan J, Berg K. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: A comparison of its photobiological properties with those of two other photosensitizers. Int J Cancer 1994; 57:883-888.
20. Sinn H. Controlled use of polyether-substituted tumor agents in diagnosis and therapy. Patent number WO93/10743, 1991.
21. Seymour LW. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst 1992;9:135-187.
22. Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989;6:193-210.
23. Westerman P, Glanzmann T, Andrejevic S, Braichotte DR, Forrer M, Wagnieres GA, Monnier P, van den Bergh H, Mach JP, Folli S. Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma. Int J Cancer 1998; 76:842-850.
24. Ris HB, Giger A, Hof VI, Mettler D, Stewart JC, Althaus U, Altermatt HJ. Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma. Eur J Cardiothorac Surg 1997;12:542-548.
25. Grahn MF, Giger A, McGuinness A, deJode ML, Stewart JCM, Ris HB, Altermatt HJ, Williams NS. mTHPC polymer conjugates: The in vivo photodynamic activity of four candidate compounds. Lasers Med Sci 1999;14:40-46.
26. Grahn MF, McGuiness A, deJode ML, Giger A, Amarpreet SD, Cheung CM, Pavitt S, Benzie R, Williams NS. In vivo photodynamic activity of mTHPC poly(ethylene) glycol conjugates (SC102). Proc SPIE 1997;3191:180-186.
27. Star WM. Light dosimetry in vivo. Phys Med Biol 1997;42: 763-787.
28. Reale FR, Griffin TW, Compton JM, Graham S, Townes PL, Bogden A. Characterization of a human malignant mesothelioma cell line (H-MESO-1): A biphasic solid and ascitic tumor model. Cancer Res 1987;47:3199-3205.
29. Begg AC. Principles and practices of the tumor-growth-delay assay. In: Kallmann RF, editor. Rodent tumor models in experimental cancer therapy. New York: Pergamon Press. 1987.
30. Rockwell S. Maintenance of tumor systems and appropriate treatment techniques for experimental tumors. In: Kallmann RF, editor. Rodent tumor models in experimental cancer therapy. New York: Pergamon Press. 1987.
31. Vulcan TG, Zhu TC, Rodriguez CE, Hsi A, Fraker DL, Baas P, Murrer LH, Star WM, Glatstein E, Yodh AG, Hahn SM. Comparison between isotropic and nonisotropic dosimetry systems during intraperitoneal photodynamic therapy. Lasers Surg Med 2000;26:292-301.
32. Marijnissen JP, Star WM. Calibration of isotropic light dosimetry probes based on scattering bulbs in clear media. Phys Med Biol 1996;41:1191-1208.
33. Van Staveren HJ, Marijnissen JPA, Aalders MCG, Star WM. Construction, quality control, and calibration of spherical isotropic fibreoptic light diffusers. Las Med Sci 1995;10:137-147.
34. Lofgren L, Larsson M, Thaning L, Hallgren S. Transthoracic endoscopic photodynamic treatment of malignant mesothelioma. Lancet 1991;337:359.
35. Pass HI, DeLaney TF, Tochner Z, Smith PE, Temeck BK, Pogrebniak HW, Kranda KC, Russo A, Friauf WS, Cole JW. Intrapleural photodynamic therapy: Results of a phase I trial. Ann Surg Oncol 1994;1:28-37.
36. Mikvy P, Messman H, MacRobert AJ, Pauer M, Sams VR, Davies CL, Stewart JC, Bown SG. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC). Br J Cancer 1997;76:713-718.
37. Ris HB, Im Hof V, Stewart CM, Mettler D, Altermatt HJ. Endobronchial photodynamic therapy: Comparison of mTHPC and polyethylene glycol-derived mTHPC on human tumor xenografts and tumor-free bronchi of minipigs. Lasers Surg Med 1998;23:25-32.
38. Veenhuizen RB, Ruevekamp-Helmers MC, Helmerhorst TJ, Kenemans P, Mooi WJ, Marijnissen JP, Stewart FA. Intraperitoneal photodynamic therapy in the rat: Comparison of toxicity profiles for photofrin and MTHPC. Int J Cancer 1994;59:830-836.
39. Hornung R, Fehr MK, Monti-Frayne J, Krasieva TB, Tromberg BJ, Berns MW, Tadir Y. Highly selective targeting of ovarian cancer with the photosensitizer PEG-m-THPC in a rat model. Photochem Photobiol 1999;70:624-629.
40. Hornung R, Jentsch B, Crompton NE, Haller U, Walt H. In vitro effects and localisation of the photosensitizers m-THPC and m-THPC MD on carcinoma cells of the human breast (MCF-7) and Chinese hamster fibroblasts (V-79). Lasers Surg Med 1997;20:443-450.
41. Ris HB, Krueger T, Giger A, Lim CK, Stewart JC, Althaus U, Altermatt HJ. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: A comparative study on human tumour xenografts. Br J Cancer 1999;79:1061-1066.
42. Hornung R, Fehr MK, Monti-Frayne J, Tromberg BJ, Berns MW, Tadir Y. Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC. Br J Cancer 1999;81:631-637.
43. Basu A, deJode M, Grahn MF, Williams NS. Comparison of cutaneous photosensitivity of mTHPC and a polyethylene glycol derivative (SC102). Lasers Surg Med 1998;22:S10: S29.
44. Ronn AM, Nouri M, Abramson AL, Pecci F. Evaluation of the third generation photosensitizer SC102 in two animal models. Lasers Med Sci 1999;14:307-318.
45. Tochner ZA, Pass HI, Smith PD, DeLaney TF, Sprague M, DeLuca AM, Harrington F, Thomas GF, Terrill R, Bacher JD. Intrathoracic photodynamic therapy: A canine normal tissue tolerance study and early clinical experience. Lasers Surg Med 1994;14:118-123.
46. Dwyer PJ, White WM, Fabian RL, Anderson RR. Optical integrating balloon device for photodynamic therapy. Lasers Surg Med 2000;26:58-66.
47. DeLaney TF, Smith PD, Thomas GF, Tochner ZA, Sindelar WF, Pass HI, Harrington FS, Bonner RF, Mitchell JB. A light-diffusing device for intraoperative photodynamic therapy in the peritoneal or pleural cavity. J Clin Laser Med Surg 1991;9:361-366.